MCF Advisors’s Tenet Healthcare THC Stock Holding History

MCF Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-131	Closed	-$7K	–	875
2022 Q3	$7K	Hold	131	–	–	﹤0.01%	593
2022 Q2	$7K	Buy	+131	New	+$9.12K	﹤0.01%	543

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

MCF Advisors's THC Position: Q4 2022 in Review

MCF Advisors sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 131 shares — an estimated $7K sold.

MCF Advisors first reported a position in THC in Q2 2022 and held it in 2 quarters. The position peaked at $7K in Q3 2022. 354 funds tracked by Wall St. Rank hold THC as of Q4 2022.

MCF Advisors reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
MCF Advisors sold 131 Tenet Healthcare shares in Q4 2022, an estimated $7K.
MCF Advisors first reported a position in Tenet Healthcare in Q2 2022 and held it in 2 quarters.
MCF Advisors's Tenet Healthcare position peaked at $7K in Q3 2022.
354 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on MCF Advisors's 13F filing for Q4 2022, filed 31 Jan 2023.